Screener
Humacyte HUMA Q2 2026 earnings
Reported August 12, 2026 · Before market open
Revenue$406.0KMiss by $634.0K
EPS-$0.16Miss by $0.05
Revenue estimate$1.0M
EPS estimate-$0.11
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$769.4K
EPS estimate-$0.09
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Humacyte report Q2 2026 earnings?
- Humacyte (HUMA) reported Q2 2026 earnings on August 12, 2026 before market open.
- What were Humacyte's Q2 2026 revenue and EPS?
- Humacyte reported revenue of $406.0K and eps of $-0.16 for Q2 2026.
- Did Humacyte beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $1.0M by $634.0K. EPS missed the consensus estimate of $-0.11 by $0.05.
- How did Humacyte's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 34.9% from $301.0K a year earlier and eps grew 33.3% from $-0.24.
- Where can I find Humacyte's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-094440) and the 10-Q periodic report (0001193125-26-347022) directly on SEC EDGAR. The filing index links above go to sec.gov.
